EOS Imaging said today that a clinical study examining the association of sagittal balance measurements and risk of falling in elderly patients reported a correlation between the falling risk and postural balance measured using its sterEOS workstation. The study results are slated to be presented at the French Rheumatology Congress in Paris this week, EOS […]
Stryker (NYSE:SYK) said yesterday that it’s eliminating the role of international president held by Ramesh Subrahmanian as it reorganizes its overseas business. After Subrahmanian’s departure, effective Dec. 31, he’s slated to stay on until March 31, 2016, as an advisor, Stryker said in a regulatory filing. International sales were down across the board during Stryker’s […]
Eos Imaging said the FDA approved its hipEos 3D software for planning hip replacement surgery.
Eos said the software uses patients’ anatomical data to create a functional, weight-bearing 3D image that can help physicians determine what size implant to use and how it should be positioned.
The market for hip and knee implants is stable but mired in a low-growth stage, according to analysts who attended the American Academy of Orthopedic Surgeons conference in San Francisco last week.
Although the abrupt departure of Stryker CEO Steve MacMillan drew the lion’s share of attention at the AAOS event, analysts from Barclays Capital and Leerink Swann agreed that the sector’s outlook calls for low-single-digit growth.
Here’s a roundup of companies announcing clearances and approvals from the Food & Drug Administration and foreign regulatory agencies. Check out MassDevice’s compilation of the latest regulatory news for additional clearances and approvals.
Biospace Med is changing its name to Eos Imaging, effective immediately, in an effort to capitalize on the name recognition of its flagship low-dose imaging device.
The Paris-based company, which has its U.S. headquarters in Cambridge, Mass., makes a full-body, low-radiation X-ray workstation called the EOS ultra-low-dose 2D/3D orthopedic imaging system.
CEO Marie Meynadier said the re-branding is aimed at leveraging "the tremendous goodwill and name recognition that we have achieved in Europe and North America," according to a press release.